-
Shares Of Chimerix Higher By Nearly 6% After Point72 Stake Reveal
Thursday, December 31, 2015 - 9:24am | 120Read More...Shares of Chimerix Inc (NASDAQ: CMRX), a biopharmaceutical company that develops and commercializes oral antivirals, surged higher by nearly 6 percent early Thursday morning after Point72 Asset Management disclosed a 5.3 percent stake in the company. Shares of Chimerix plunged more than 80 percent...
-
Chimerix Ditched Its Ebola Treatment To Focus On Cytomegalovirus...And It Just Whiffed Phase 3 Trials
Monday, December 28, 2015 - 10:30am | 280Read More...Chimerix Inc (NASDAQ: CMRX) shares are down more than 77 percent on Monday morning after the company issued a press release that revealed it has missed a primary endpoint on its Phase 3 trial of brincidofovir for patients with cytomegalovirus (CMV) infection. Brincidofovir has been in development...
-
Why Shares Of Chimerix Were Halted
Monday, December 28, 2015 - 8:52am | 232Read More...Shares of Chimerix Inc (NASDAQ: CMRX) were halted at around 7:25 a.m. ET on Monday. Chimerix, a biopharmaceutical company that develops antivirals in areas of high unmet medical need, announced in a press release that a Phase 3 study for its SUPPRESS of brincidofovir in patients undergoing...
-
Dow Suffers Largest Daily Decline Since July, S&P 500 At 8-Week Lows On Global Growth Concerns
Tuesday, October 7, 2014 - 4:52pm | 2340Read More...U.S. stocks tumbled with the three major indices each shedding more than 1.5 percent as global economic growth concerns surfaced. The IMF lowered its global growth forecast for 2014 to 3.3 percent from a previous 3.4 percent. The agency also lowered its 2015 global growth projections to 3.8...
